Key Metrics
7.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.87
5-Year SI
5-year SI
- 0.87 2-year SI
- 0.86 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Immunology
SJR
- Q2 Immunology
- Q1 Rheumatology
- Q2 Immunology and Allergy
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.72
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
17%
4 to 6 months
65%
7 to 9 months
14%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Disease activity
- Colchicine
- Rheumatoid arthritis
- Methotrexate
- Glucocorticoid
- Systematic review
- Placebo
- Adalimumab
- Psoriatic arthritis
- Rheumatology
- Cross-sectional study
- Rituximab
- Janus kinase inhibitor
- Interleukin
- Myositis
- Risk of infection
- Ankylosing spondylitis
- Bone formation
- Alcohol consumption
- Osteoarthritis
Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | GBP 2060 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | EULAR |
| Frequency | Semi-annual |
| Publication Start Year | 2015 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 14 |
| Article Processing Charges | GBP 2060 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in RMD Open ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-γR/STAT1 pathway in the treatment of rheumatoid arthritis
- 7 Nov 24
- RMD Open
-
Full paper
Chronic kidney disease in patients with psoriatic arthritis: a cohort study
- 7 Nov 24
- RMD Open
-
Full paper
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries.
- 1 Nov 24
- RMD open
-
Full paper
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis
- 1 Nov 24
- RMD Open
-
Full paper
Is rheumatoid arthritis always preceded by a symptomatic at-risk phase of arthralgia?
- 1 Nov 24
- RMD Open
-
Full paper
Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
- 1 Nov 24
- RMD Open
Scite analysis
Powered by scite_
1.6k articles received 22.7k citations see all
- 1,160 Supporting
- 20,222 Mentioning
- 176 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 46 Corrections
- 35 Errata
- 0 Expression of Concern
FAQs
How long has RMD Open been actively publishing?
RMD Open has been in operation since 2015 till date.
What is the publishing frequency of RMD Open ?
RMD Open published with a Semi-annual frequency.
How many articles did RMD Open publish last years ?
In 2023, RMD Open published 310 articles.
What is the eISSN & pISSN for RMD Open ?
For RMD Open,eISSN is 2056-5933 and pISSN is2056-5933.
What is Citescore for RMD Open ?
Citescore for RMD Open is 7.1.
What is SNIP score for RMD Open ?
SNIP score for RMD Open is 1.72.
What is the SJR for RMD Open ?
SJR for RMD Open is Q2.
Who is the publisher of RMD Open ?
BMJ PUBLISHING GROUP is the publisher of RMD Open.